Cassidy Cooper, PA
Physician Assistant · Bradford, ARNPI 1275099475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,354, more than ten times the $10 reported in 2021. Among physician assistant clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$841
- Sanofi-aventis U.S. LLC$788
- Novo Nordisk$579
- Abbott$430
- BETA Bionics, Inc.$372
- Dexcom, Inc.$369
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,73099%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 31 | $841 |
| Sanofi-aventis U.S. LLC | 22 | $788 |
| Novo Nordisk | 29 | $579 |
| Abbott | 45 | $430 |
| BETA Bionics, Inc. | 9 | $372 |
| Dexcom, Inc. | 12 | $369 |
| Lilly USA, LLC | 17 | $309 |
| Corcept Therapeutics | 10 | $225 |
| Neurocrine Biosciences, Inc. | 5 | $219 |
| Tandem Diabetes Care, Inc. | 8 | $205 |
| Sequel Med Tech, LLC | 4 | $189 |
| Radius Health, Inc. | 5 | $131 |
| AbbVie | 5 | $116 |
| Xeris Pharmaceuticals, Inc. | 6 | $113 |
| Boehringer Ingelheim | 6 | $113 |
| Recordati_rare_diseases_inc. | 5 | $110 |
| Insulet Corporation | 3 | $106 |
| Mannkind Corporation | 3 | $101 |
| Novartis | 2 | $52 |
| Rhythm Pharmaceuticals, Inc. | 2 | $48 |
| Amneal Pharmaceuticals LLC | 2 | $47 |
| Averitas Pharma Inc. | 2 | $45 |
| Kyowa Kirin, Inc. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Ascendis Pharma Endocrinology Inc | 2 | $38 |
| Bayer | 2 | $38 |
| Merck | 2 | $32 |
| AstraZeneca | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| Pfizer | 1 | $17 |
| Almatica Pharma LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$708
- TZIELD$259
- DEXCOM G7 GSS (161)$250
- EVENITY$249
- TWIIST$127
- FreeStyle Libre$125
- Ozempic$119
- Repatha$113
- CRENESSITY$110
How this compares
$5,815 in reported general payments places this provider in the 90th percentile of 451 physician assistant providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 420 | $475,999 |
| MounjaroTirzepatide | 175 | $213,317 |
| TrulicityDulaglutide | 106 | $114,840 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 114 | $112,969 |
| Tresiba Flextouch U-100Insulin Degludec | 137 | $99,653 |
| Tresiba Flextouch U-200Insulin Degludec | 40 | $78,975 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 84 | $72,082 |
| Novolog FlexpenInsulin Aspart | 222 | $67,956 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 88 | $62,884 |
| JardianceEmpagliflozin | 46 | $59,708 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 334 | $48,598 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $46,821 |
| Humalog Kwikpen U-100Insulin Lispro | 125 | $34,028 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 67 | $30,344 |
| FarxigaDapagliflozin Propanediol | 41 | $28,881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus | $579 | $515,226449 claims |
| Lilly USA, LLCMounjaro, Trulicity | $309 | $328,157281 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $788 | $112,969114 claims |
| Boehringer IngelheimJardiance | $113 | $59,70846 claims |
| AstraZenecaFarxiga | $27 | $28,88141 claims |
| AbbVieSynthroid | $116 | $2,23637 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $47 | $1,719318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 451 physician assistant providers in Arkansas.
Other physician assistant in Bradford
- Honey SchaumburgFort Smith$397K
- Adrienne EasterlingRogers$366K
- Katherine RossLittle Rock$44K
- Benton LoggainsFort Smith$39K
- Monte DouglasJacksonville$38K
- Anna StilinovicFayetteville$32K
- Timothy BookerLittle Rock$13K
- Callie PooleJonesboro$12K
- Bryce BassFort Smith$11K
- Kayla MouryFort Smith$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.